DeJuan Lowe v. Nancy B. Marthakis

Summary

The opinion addresses a prisoner’s Eighth Amendment claim against a prison medical director, alleging deliberate indifference to his ulcerative colitis and Crohn’s disease treatment. It evaluates the defendant’s motion for summary judgment under the deliberate-indifference standard, focusing on the medical care provided, specialist referrals, treatment authorizations, medication and dietary compliance, and alleged delays in specialty and surgical consultations. The provided text ends before the court’s ultimate disposition is stated.

Holdings

1. Lowe failed to present evidence from which a reasonable jury could conclude that Dr. Marthakis's treatment of his ulcerative colitis and suspected Crohn's disease was plainly inappropriate or violated an applicable standard of care; therefore, the Eighth Amendment deliberate-indifference claim could not survive summary judgment.
2. Dr. Marthakis was not deliberately indifferent by submitting the surgical-consultation request in June 2022 rather than earlier because the record showed she followed the revised recommendations from the gastroenterology specialists and submitted the request after a specialist again recommended surgical consultation.
3. Dr. Marthakis was not deliberately indifferent by declining to unilaterally provide biologic medications such as Humira because no gastroenterology specialist recommended such medication during the period of her care and the undisputed evidence supported deferring to the specialists' treatment plans.

Questions Presented

1. Whether Lowe presented sufficient evidence for a reasonable jury to find that Dr. Marthakis was deliberately indifferent to an objectively serious medical need under the Eighth Amendment.
2. Whether Dr. Marthakis's alleged delay in submitting an off-site provider request for a surgical consultation constituted deliberately indifferent medical treatment.
3. Whether Dr. Marthakis acted with deliberate indifference by providing aminosalicylate medications and steroids rather than biologic medications such as Humira.

Disposition

other